Express News | IGC Pharma Announces Interim Results For IGC-AD1 In Reducing Alzheimer's Agitation; Results Indicate That IGC-AD1 Clinically Reduced Agitation Compared To Placebo
BenzingaApr 26 11:19 ET
Express News | IGC Pharma Inc- Results Indicate That IGC-AD1 Clinically Reduced Agitation Compared to Placebo
ReutersApr 26 11:17 ET
Express News | IGC Pharma Inc- Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
ReutersApr 26 11:17 ET
Express News | IGC Pharma Inc Files for Resale of up to 8.8 Mln Shares by the Selling Stockholder - SEC Filing
Moomoo 24/7Apr 18 06:05 ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersClene (NASDAQ:CLNN) shares moved upwards by 54.9% to $0.48 during Tuesday's after-market session. The company's market cap stands at $61.6 million. Talphera (NASDAQ:TLPH) shares moved upwards b
BenzingaApr 16 16:31 ET
IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer's-Associated Agitation
Tuesday, IGC Pharma Inc (NYSE:IGC) released interim data from its Phase 2 clinical trial of IGC-AD1 for agitation in dementia associated with Alzheimer's.The data demonstrates a clinically significant
BenzingaApr 16 11:47 ET
Express News | IGC Pharma Shares Are Trading Higher After Interim Phase 2 Data Showed a Reduction in Alzheimer's Agitation at Week Two
Moomoo 24/7Apr 16 07:03 ET
Express News | IGC Pharma Announces Interim Phase 2 Data Showing IGC-AD1 Achieved Secondary Endpoint And Demonstrated A Clinical Reduction In Alzheimer's Agitation At Week Two
Moomoo 24/7Apr 16 07:02 ET
Express News | IGC Pharma: Demonstrates Clinical Reduction, Approaching Statistical Significance, at Week Two, in Agitation in Dementia Due to Alzheimer's in Study
Moomoo 24/7Apr 16 07:01 ET
Express News | IGC Pharma Inc: Study Achieves Secondary End Point
Moomoo 24/7Apr 16 07:01 ET
Express News | IGC-Ad1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
Moomoo 24/7Apr 16 07:00 ET
Express News | 'FDA Head Says There's 'No Reason For DEA To Delay' Rescheduling Marijuana' - Marijuana Moment
Moomoo 24/7Apr 11 14:14 ET
IGC Pharma Adds Advisor in Artificial Intelligence
Business WireApr 9 09:00 ET
IGC Pharma, Inc. (IGC) Soars in After Market After Positive Alzheimer's Research Results
IGC Pharma, Inc. (NYSE: IGC) witnessed an unprecedented surge in its stock price following the release of encouraging phase 2 results in Alzheimer's research. The initial uptick of 19.5% during trading hours was just the beginning of an exhilarating journey, as the afterhours session saw an additional 15% spike, propelling the stock beyond its 52-week ...
Stocks TelegraphApr 4 03:55 ET
Express News | Shares of Cannabis Stocks Are Trading Higher After Florida's Supreme Court Recently Approved a Cannabis Legalization Proposal for the November Election. The Sector May Also Be Gaining After Germany's Cannabis Possession Legalization Took Effect on Apr. 1
Moomoo 24/7Apr 3 11:08 ET
Express News | Shares of Cannabis Stocks Are Trading Higher After Florida's Supreme Court Approved a Cannabis Legalization Proposal for the November Election. The Sector May Also Be Gaining After Germany's Cannabis Possession Legalization Took Effect on Apr. 1
Moomoo 24/7Apr 2 11:28 ET
'GOP Senators Tell DEA To Reject Marijuana Rescheduling, Arguing It Would Violate International Treaties' - Marijuana Moment
Three Republican senators are urging the Drug Enforcement Administration (DEA) to reject the top federal health agency's marijuana rescheduling recommendation, arguing that it would put the U.S. out o
BenzingaMar 27 11:44 ET
IGC Pharma Announces $3 Million Unregistered Private Placement of Its Common Stock
IGC Pharma, Inc. (NYSE:IGC) ("IGC" or the "Company") today announced a $3 million strategic investment from funds managed by Bradbury Asset Management (Hong Kong) Limited ("Bradbury"), a leading asset management
BusinesswireMar 26 15:00 ET
'Three In Five Americans Want Congress To Pass Marijuana Banking Reform, American Bankers Associations Poll Finds Amid Renewed Push' - Marijuana Moment
A new poll from the American Bankers Association (ABA) shows that roughly three out of five Americans support allowing marijuana industry access to the banking system—a finding that comes amid a renewed push for reform among congressional leaders.
BenzingaMar 25 10:16 ET
EXCLUSIVE: Revolutionary Alzheimer's Drug By IGC Shows Early Success
In a massive stride towards Alzheimer's treatment, IGC Pharma (NYSE:IGC) recently revealed promising interim results for their pioneering drug, IGC-AD1, aimed at mitigating agitation in Alzheimer's pa
BenzingaMar 20 14:02 ET
No Data
No Data